MENU
RADX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Radiopharm Theranostics (RADX) Ownership - Who owns Radiopharm Theranostics?

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
33.14M
P/E Ratio
N/A
Total Cash
36.44M
Projected Growth
N/A
Total Debt
N/A
Revenue
1.68M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.62
Total Debt/Equity
N/A
Revenue/Share
0.32 USD as % of share price
View a ticker or compare two or three
RADX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details